Mendus
Clinical-stage company developing immunotherapies to prevent tumor recurrence.
IMMU | ST
Overview
Corporate Details
- ISIN(s):
- SE0005003654 (+1 more)
- LEI:
- 529900AFBGFR7ZB50J95
- Country:
- Sweden
- Address:
- Västra Trädgårdsgatan 15, 111 53 Stockholm
- Website:
- https://mendus.com/
- Sector:
- Manufacturing
Description
Mendus is a clinical-stage company developing immunotherapies to improve long-term survival for cancer patients. The company's primary focus is on preventing tumor recurrence, a leading cause of cancer-related mortality. By leveraging its expertise in allogeneic dendritic cell biology, Mendus designs therapies that stimulate the immune system to build active and long-lasting immunity against residual cancer cells. This approach aims to change the course of cancer treatment by offering durable responses while preserving the patient's quality of life. The company's pipeline is centered on maintenance therapies for various forms of cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-06 08:00 |
Mendus tillkännager valberedning inför årsstämman 2026
|
Swedish | PDF • 118.2 KB | ||
| 2025-10-02 08:00 |
Mendus meddelar uppdaterad klinisk strategi och operativt fokus
|
Swedish | PDF • 138.6 KB | ||
| 2025-10-02 08:00 |
Mendus announces updated clinical strategy and operational focus
|
English | PDF • 137.5 KB | ||
| 2025-08-21 08:00 | Swedish | PDF • 1.4 MB | |||
| 2025-08-21 08:00 | English | PDF • 1.4 MB | |||
| 2025-08-20 18:00 |
Mendus AB (publ) has resolved to transfer own shares on Nasdaq Stockholm
|
English | PDF • 117.2 KB | ||
| 2025-08-20 18:00 |
Mendus AB (publ) har beslutat om överlåtelse av egna aktier
|
Swedish | PDF • 117.4 KB | ||
| 2025-06-30 08:00 |
Ändring av antalet aktier och röster i Mendus AB (publ)
|
Swedish | PDF • 124.2 KB | ||
| 2025-06-30 08:00 |
Change in number of shares and votes in Mendus AB (publ)
|
English | PDF • 123.6 KB | ||
| 2025-05-26 17:50 |
Mendus AB (publ) har beslutat om emission av C-aktier och överlåtelse av egna s…
|
Swedish | PDF • 117.6 KB | ||
| 2025-05-26 17:50 |
Mendus AB (publ) has decided on directed issues of Class C shares and transfer …
|
English | PDF • 118.1 KB | ||
| 2025-05-06 10:10 |
Kommuniké från årsstämma i Mendus AB (publ) den 6 maj 2025
|
Swedish | PDF • 128.6 KB | ||
| 2025-05-06 10:10 |
Report from the Annual General Meeting of Mendus AB (publ) on 6 May 2025
|
English | PDF • 128.9 KB | ||
| 2025-05-06 08:00 | Swedish | PDF • 1.4 MB | |||
| 2025-05-06 08:00 | English | PDF • 1.4 MB |
Automate Your Workflow. Get a real-time feed of all Mendus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Mendus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Mendus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-19 | Ann-Charlotte Ferm | Other | Buy | 100,000 | 215,900.00 SEK |
| 2022-02-24 | Jeroen Rovers | Other | Buy | 10,000 | 22,100.00 SEK |
| 2022-02-23 | Ann-Charlotte Ferm | Other | Buy | 10,000 | 25,650.00 SEK |
| 2022-02-23 | Erik Manting | Other | Buy | 84,000 | 211,680.00 SEK |
| 2022-02-22 | Ann-Charlotte Ferm | Other | Buy | 10,000 | 23,639.00 SEK |
| 2022-02-22 | Ann-Charlotte Ferm | Other | Buy | 10,000 | 23,394.00 SEK |
| 2022-02-22 | Ann-Charlotte Ferm | Other | Buy | 20,000 | 47,472.00 SEK |
| 2021-12-28 | Johannes Preusting | Other | Buy | 22,500 | 89,100.00 SEK |
| 2021-12-27 | Johannes Preusting | Other | Buy | 27,500 | 97,625.00 SEK |
| 2021-12-23 | Christine Lind | Other | Buy | 30,000 | 104,100.00 SEK |
Peer Companies
